癌症中的BRAF V600E:探索结构复杂性,突变特征和途径失调
Jayhind Bharti1, Priyadharshini Gogu1, Sarvesh Kumar Pandey2
1Drug Discovery Laboratory, School of Pharmacy, GITAM (Deemed to be) University, Hyderabad Campus, 502329, India.
Experimental cell research
|February 17, 2025
概括
BRAFV600E突变通过产生过度活跃的BRAF蛋白来驱动癌症,导致不受控制的细胞生长. 针对由此产生的失调途径为BRAF突变癌症提供了治疗机会.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 在癌症中,BRAF突变很常见,其中V600E是主要的变异.
- 了解BRAF V600E的结构影响是了解癌症机制的关键.
研究的目的:
- 审查BRAF突变类及其在瘤发生中的作用.
- 为了阐明BRAFV600E对细胞信号通路的影响.
- 突出针对BRAF驱动的恶性瘤的治疗策略.
主要方法:
- 关于BRAF突变和相关信号通路的科学文献的审查.
- 分析野生型BRAF和BRAFV600E之间的结构差异.
- 讨论失调的通路,包括MAPK/ERK,PI3K/AKT/mTOR,TP53,DDR,以及WNT/β-catenin.
主要成果:
- BRAFV600E突变导致构成性活性激酶域,促进癌症的特征.
- 根据遗传改变,BRAF突变被分为三个不同的组.
- 失调的信号通路是BRAF突变癌症瘤发生和进展的关键驱动因素.
结论:
- BRAF失调是癌症发展和进展的核心.
- 针对BRAF突变癌症中的失调途径具有显著的治疗潜力.
- 对BRAF驱动的恶性瘤的进一步研究可以导致改善治疗策略.
关键词:
血管新生的产生.这就是BRAF.在BRAF V600E中使用.这种BRAF突变是BRAF突变.在DDR中,DDR是指DDR.在MAPK/ERKK中.在PI3K/AKT/mTOR中使用.这就是TP53的特点.更多相关视频
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.0K
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
2.9K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mutations
33.1K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
33.1K
